Current Stem Cell Research & Therapy Registers its 1st Impact Factor
News release date: June 27, 2013
Bussum, Netherlands, June 27, 2013: Current Stem Cell Research & Therapy has registered its first Impact Factor at 2.963. The Impact Factor ranking has been awarded by Journal Citation Reports®, which are annually published by the Institute of Scientific Information, a division of Thomson Reuters. Its purpose is to offer a systematic means to critically evaluate the world's leading journals, with quantifiable, statistical information based on citation data.
Current Stem Cell Research & Therapy publishes high quality frontier reviews, drug clinical trial studies and guest edited issues on all aspects of basic research on stem cells and their uses in clinical therapy.